The independent source for health policy research, polling, and news.
Dozens of protesters were injured in recent protests, triggering efforts to limit or ban the use of rubber bullets and other projectiles.
The county, a hotbed of coronavirus infection in California, has seen a steady reduction in positive test results, new cases, hospitalizations and deaths over the past few weeks. But officials are concerned about public behavior over the Labor Day holiday weekend and wary of relaxing strictures too soon.
Older Blacks are perishing quietly, out of sight, victims of the pandemic and a lifetime of racism and its attendant adverse health effects.
The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they’ll opt instead to use the scarce resource to complete a clinical trial.
KHN Midwest editor and correspondent Laura Ungar appeared on Spectrum News and Fox 35 Orlando to discuss cuts to Florida’s public health system that have hampered its response to the coronavirus pandemic.
As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools ― and a unified plan ― to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.
As gyms throughout New York City had to close because of the coronavirus pandemic, some trainers just moved outdoors to the parks.
The nation’s top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
KHN senior Colorado correspondent Markian Hawryluk joined KUNC’s Erin O’Toole on “Colorado Edition” to discuss how the growing favorability of the Affordable Care Act could play a role in determining who wins control of the U.S. Senate this fall.
The measure caps one of the most contentious health policy debates in recent memory, potentially altering how Californians get their medical care. Gov. Gavin Newsom has until the end of September to sign or veto it.
California could become the first state to develop its own line of generic drugs under a bill approved Monday by the legislature. The measure heads to Gov. Gavin Newsom for consideration.
Tension rises among residents and travelers as U.S. island territories work to stymie the coronavirus while attempting to keep their doors open to tourism.
This pandemic is like war, and California’s local health officers are leading the state’s response. Yet unlike war heroes, who are lionized, they are facing unprecedented attacks and death threats.
Virtual classrooms are aggravating the economic disparities that plague education, with widening divides in access to supplies, workspace and parental guidance. The problem is especially acute for children with learning disabilities.
The pandemic has led medical schools to cancel many of the rotations in hospitals and clinics that students perform to see a broad mix of patients with a diverse mix of problems.
Donald Trump accepted his party’s nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.
A robust sign-up for flu shots could help head off a nightmare scenario in the coming winter of hospitals stuffed with both COVID-19 patients and those suffering from severe effects of influenza. Plus, no one knows how flu and COVID might interact if a patient got both.
As the twin disasters of COVID-19 and fire season sweep through California, thousands of residents are weighing difficult options, pitting risk against risk as they decide where to evacuate. Amid a virulent pandemic, where can you safely relocate?
Control of the U.S. Senate this election hinges on a handful of vulnerable GOP incumbents. Their opposition to the Affordable Care Act could be their undoing.
President Donald Trump touted the Food and Drug Administration’s approval of this unproven COVID-19 treatment for emergency use. That set off reactions ranging from excitement and optimism to scientific concerns and criticism that the decision was politically motivated.
